Cogentus utilizes a capital-efficient business model that leverages its inventive, deeply-experienced internal and external professionals to systematically and rapidly identify, evaluate and develop unique combination prescription pharmaceutical products.
The company's products derive from leads generated internally or via external sources based on licensing and/or corporate collaborations.
Cogentus applies excellence to the elaboration of product concepts, the establishment of commercial and intellectual property strategies, and the design and execution of product development plans.
The company's approach supports optimal probabilities of success and efficient product approvals.
